{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "L328M",
          "alt": "S123V",
          "position": "123"
        },
        "variant_string_id": "PARK2 L328M"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Define the disease mechanism",
          "extracted_paper_info": "The paper states that PARK2 mutations are linked to Parkinson's Disease and that this loss of the protein likely triggers neurodegeneration.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PARK2 loss to Parkinson's pathogenesis and suggests a disruption in protein degradation."
        },
        {
          "step_name": "Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper describes a gene expression assay to assess PARK2 protein levels.",
          "judgment": "Yes",
          "reasoning": "The paper's methodology uses a gene expression assay, which is a standard approach for assessing protein levels and is relevant to the described mechanistic event."
        },
        {
          "step_name": "Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper uses a western blot to verify protein expression levels.",
          "judgment": "Yes",
          "reasoning": "The paperâ€™s methodology utilizes a western blot to confirm a crucial aspect of the process."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper reports that mutations of PARK2 cause AR-JP. The mutation results in the loss of the protein that is the primary driver of the neurodegenerative process.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that the mutation is the cause of AR-JP, linking the loss of the protein to the disease's progression."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper describes the initial results of the gene expression assay that show the loss of the PARK2 protein.",
          "judgment": "Yes",
          "reasoning": "The gene expression assay demonstrates loss of the protein, providing the evidence in the study."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The evidence strongly suggests a causal relationship between the PARK2 mutation and the progression of AR-JP, highlighting the critical role of this loss of protein degradation in the neurodegenerative process."
    }
  ]
}